We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 83

Full Court warns against dangerous affliction of parameteritis (and confirms invalidity of aripiprazole patent)
  • King & Wood Mallesons
  • Australia
  • August 26 2016

On Wednesday the Full Court of the Federal Court of Australia handed down a decision in which it upheld Justice Yates' findings that Otsuka's patent


Generic Health succeeds in invalidating patent for aripiprazole: Otsuka Pharmaceutical Co., Ltd v Generic Health Pty Ltd (No 4) 2015 FCA 634
  • King & Wood Mallesons
  • Australia
  • July 7 2015

Generic Health is perhaps a step closer to bringing its generic version of the antipsychotic drug aripiprazole to market in Australia after Justice


Just genes? Lessons from the Myriad litigation
  • King & Wood Mallesons
  • Australia
  • August 19 2013

Last month the United States Supreme Court ruled that certain naturally occurring DNA sequences (the BRCA1 and BRCA2 genes, mutations in which are


Federal Court holds that employers can require employees to provide medical reports and undergo medical examinations
  • King & Wood Mallesons
  • Australia
  • March 25 2014

The Federal Court has provided guidance on when an employer can require an employee to obtain a medical report or undergo a medical examination in


The image of deception
  • King & Wood Mallesons
  • Australia
  • March 14 2014

On 10 March 2014, the Federal Court of Australia found that Breast Check Pty Ltd engaged in misleading or deceptive conduct and made false


Blockbuster drug goes bust? The Federal Court finds three AstraZeneca patents relating to Crestor (rosuvastatin) invalid
  • King & Wood Mallesons
  • Australia
  • March 7 2013

In an important decision handed down on Tuesday, Justice Jagot of the Federal Court held that three patents relating to the blockbuster drug Crestor


Homeopathy plus! Not immune from the ACL
  • King & Wood Mallesons
  • Australia
  • March 7 2013

On 21 February 2013, the ACCC instituted proceedings against Homeopathy Plus! Australia Pty Ltd ("Homeopathy Plus!") in the Federal Court of


Breaking news High Court hands down important decision in relation to infringement of pharmaceutical patents
  • King & Wood Mallesons
  • Australia
  • December 4 2013

A few hours ago, the High Court handed down its long awaited decision in Apotex v Sanofi. While the High Court confirmed that methods of medical


European Commission ups the cost of paying for delay
  • King & Wood Mallesons
  • Australia, European Union, USA
  • August 13 2012

On 25 July 2012, the EC alleged that Danish pharmaceutical company Lundbeck violated EU antitrust rules by colluding to prevent other pharma companies from marketing generic versions of its best-seller antidepressant, citalopram


Federal Court prescribes hard medicine for Vioxx class action
  • King & Wood Mallesons
  • Australia
  • March 15 2012

The full court of the Federal Court of Australia recently overturned a damages award in the VIOXX class action, confirming once again that issues of causation are no less difficult to prove in large-scale class actions than in individual proceedings